Evaluation of a pharmacist intervention on patients initiating pharmacological treatment for depression: A randomized controlled superiority trial

European Neuropsychopharmacology

Volumn 23, Issue 9, 2013, Pages 1057-1066

  Rubio Valera, Maria ^a,b   March Pujol, Marian ^c   Fernández, Ana ^a,b,d   Peñarrubia María, M Teresa ^b,e   Travé, Pere ^c   López del Hoyo, Yolanda ^b,f   Serrano Blanco, Antoni ^a,b  

^a Research and Development Unit   (Spain)

^b Promoción de la Salud en Atención Primaria RedIAPP RD06 0018 0017   (Spain)

^c UNIVERSITY OF BARCELONA   (Spain)

^d UNIVERSITAT AUTÒNOMA DE BARCELONA   (Spain)

^e INSTITUT CATALÀ DE LA SALUT   (Spain)

^f UNIVERSITY OF ZARAGOZA   (Spain)

Author keywords

Antidepressive agents; Depressive disorder; Medication adherence; Pharmaceutical services; Primary health care

Indexed keywords

ANTIDEPRESSANT AGENT;

ADULT; ARTICLE; COMMUNITY CARE; CONTROLLED STUDY; DISEASE SEVERITY; FEMALE; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; MAJOR DEPRESSION; MALE; MENTAL HEALTH SERVICE; MENTAL PATIENT; MULTICENTER STUDY; OUTCOME ASSESSMENT; PATIENT COMPLIANCE; PATIENT SATISFACTION; PHARMACIST; PRIMARY MEDICAL CARE; PRIORITY JOURNAL; PSYCHOPHARMACOTHERAPY; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL;

ANTIDEPRESSIVE AGENTS; DEPRESSIVE DISORDER; MEDICATION ADHERENCE; PHARMACEUTICAL SERVICES; PRIMARY HEALTH CARE;

ADULT; ANTIDEPRESSIVE AGENTS; COMMUNITY PHARMACY SERVICES; DEPRESSIVE DISORDER, MAJOR; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; PATIENT PARTICIPATION; PHARMACISTS; PROFESSIONAL ROLE; TREATMENT OUTCOME;

EID: 84884209438     PISSN: 0924977X     EISSN: 18737862     Source Type: Journal    
DOI: 10.1016/j.euroneuro.2012.11.006     Document Type: Article

References (35)

1. Adler D.A., Bungay K.M., Wilson I.B., Pei Y., Supran S., Peckham E., Cynn D.J., Rogers W.H. The impact of a pharmacist intervention on 6-month outcomes in depressed primary care patients. Gen. Hosp. Psychiatry 2004, 26(3):199-209. (available from: PM:15121348).
2. Alonso J., Angermeyer M.C., Bernert S., Bruffaerts R., Brugha T.S., Bryson H., De Girolamo G., Graaf R., Demyttenaere K., Gasquet I., Haro J.M., Katz S.J., Kessler R.C., Kovess V., Lepine J.P., Ormel J., Polidori G., Russo L.J., Vilagut G., Almansa J., Arbabzadeh-Bouchez S., Autonell J., Bernal M., Buist-Bouwman M.A., Codony M., Domingo-Salvany A., Ferrer M., Joo S.S., Martinez-Alonso M., Matschinger H., Mazzi F., Morgan Z., Morosini P., Palacin C., Romera B., Taub N., Vollebergh W.A. Prevalence of mental disorders in Europe: results from the European Study of the Epidemiology of Mental Disorders (ESEMeD) project. Acta Psychiatr. Scand. 2004, Suppl. 109(420):21. (available from: PM:15128384).
3. Angst J., Angst F., Stassen H.H. Suicide risk in patients with major depressive disorder. J. Clin. Psychiatry 1999, 60(Suppl. 2):57-62. (discussion 75-76, 113-116, 57-62).
4. Armando P.D., Martinez P., Marti P.M., Sola Uthurry N.H., Faus Dader M.J. Development and validation of a Spanish language patient satisfaction questionnaire with drug dispensing. Pharm. World Sci. 2008, 30(2):169-174. (available from: PM:17885819).
5. Badia X., Roset M., Montserrat S., Herdman M., Segura A. The Spanish version of EuroQol: a description and its applications. European Quality of Life scale. Med. Clin. (Barc.) 1999, 112(Suppl. 1):79-85.
6. Badia X., Schiaffino A., Alonso J., Herdman M. Using the EuroQoI 5-D in the Catalan general population: feasibility and construct validity. Qual. Life Res. 1998, 7(4):311-322.
7. Bower P., Gilbody S., Richards D., Fletcher J., Sutton A. Collaborative care for depression in primary care. Making sense of a complex intervention: systematic review and meta-regression. Br. J Psychiatry 2006, 189:484-493. (available from: PM:17139031).
8. Brook O., van Hout H., de Haan M., Nieuwenhuyse H. Pharmacist coaching of antidepressant users, effects on adherence, depressive symptoms and drug attitude; a randomized controlled trial. Eur. Neuropsychopharmacol. 2002, 12(3):S201-S202. (available from: ISI:000178905000201).
9. Brook O.H., van Hout H., Stalman W., Nieuwenhuyse H., Bakker B., Heerdink E., de Haan M. A pharmacy-based coaching program to improve adherence to antidepressant treatment among primary care patients. Psychiatr. Serv. 2005, 56(4):487-489. (available from: PM:15812103).
10. Bull S.A., Hu X.H., Hunkeler E.M., Lee J.Y., Ming E.E., Markson L.E., Fireman B. Discontinuation of use and switching of antidepressants: influence of patient-physician communication. J. Am. Med. Assoc. 2002, 288(11):1403-1409. (available from: PM:12234237).
11. Capoccia K.L., Boudreau D.M., Blough D.K., Ellsworth A.J., Clark D.R., Stevens N.G., Katon W.J., Sullivan S.D. Randomized trial of pharmacist interventions to improve depression care and outcomes in primary care. Am. J. Health Syst. Pharm. 2004, 61(4):364-372. (available from: PM:15011764).
12. Cohen J. Statistical Power Analyses for the Behavioral Sciences 1988, Erlbaum, Hillsdale, New Jersey.
13. Dolan, P., Gudex, C., Kind, P., Williams, A., 1995. A Social Tariff for EuroQol: Results From a UK General Population Survey. Discussion Paper 138. Centre for Health Economics, University of York.
14. Finley P.R., Rens H.R., Pont J.T., Gess S.L., Louie C., Bull S.A., Lee J.Y., Bero L.A. Impact of a collaborative care model on depression in a primary care setting: a randomized controlled trial. Pharmacotherapy 2003, 23(9):1175-1185. (available from: PM:14524649).
15. First M.B., Spitzer R.L., Gibbon M., William J.B. Structured Clinical Interview Axis I DSM-IV Disorders, Research Version (SCID-RV) 1996, American Psychiatric Press, Inc., Washington.
16. First M.B., Spitzer R.L., Gibbon M., William J.B. Entrevista clínica estructurada para los trastornos del eje I del DSM-IV 1999, Masson ed., Barcelona, Spain.
17. Geddes J.R., Carney S.M., Davies C., Furukawa T.A., Kupfer D.J., Frank E., Goodwin G.M. Relapse prevention with antidepressant drug treatment in depressive disorders: a systematic review. Lancet 2003, 361(9358):653-661.
18. Hansen R.A., Kim M.M., Song L., Tu W., Wu J., Murray M.D. Comparison of methods to assess medication adherence and classify nonadherence. Ann. Pharmacother. 2009, 43(3):413-422.
19. Kroenke K., Spitzer R.L., Williams J.B. The PHQ-9: validity of a brief depression severity measure. J. Gen. Intern. Med. 2001, 16(9):606-613.
20. Lingam R., Scott J. Treatment non-adherence in affective disorders. Acta Psychiatr. Scand. 2002, 105(3):164-172.
21. Mathers C.D., Loncar D. Projections of global mortality and burden of disease from 2002 to 2030. PLoS Med. 2006, 3(11):e442. (available from: PM:17132052).
22. Peterson A.M., Nau D.P., Cramer J.A., Benner J., Gwadry-Sridhar F., Nichol M. A checklist for medication compliance and persistence studies using retrospective databases. Value Health 2007, 10(1):3-12.
23. Pinto-Meza A., Fernandez A., Serrano-Blanco A., Haro J.M. Adequacy of antidepressant treatment in Spanish primary care: a naturalistic six-month follow-up study. Psychiatr. Serv. 2008, 59(1):78-83.
24. Rickles N.M., Svarstad B.L., Statz-Paynter J.L., Taylor L.V., Kobak K.A. Improving patient feedback about and outcomes with antidepressant treatment: a study in eight community pharmacies. J. Am. Pharm. Assoc. (2003) 2006, 46(1):25-32. (available from: PM:16529338).
25. Rubio-Valera M., Serrano-Blanco A., Magdalena-Belio J., Fernandez A., Garcia-Campayo J., Pujol M.M., del Hoyo Y.L. Effectiveness of pharmacist care in the improvement of adherence to antidepressants: a systematic review and meta-analysis. Ann. Pharmacother. 2011, 45(1):39-48.
26. Rubio-Valera M., Serrano-Blanco A., Trave P., Penarrubia-Maria M.T., Ruiz M., Pujol M.M. Community pharmacist intervention in depressed primary care patients (PRODEFAR study): randomized controlled trial protocol. BMC Public Health 2009, 9:284.
27. Salvador-Carulla L., Bendeck M., Fernandez A., Alberti C., Sabes-Figuera R., Molina C., Knapp M. Costs of depression in Catalonia (Spain). J. Affect. Disord. 2011, 132(1-2):130-138.
28. Serna M.C., Cruz I., Real J., Gasco E., Galvan L. Duration and adherence of antidepressant treatment (2003 to 2007) based on prescription database. Eur. Psychiatry 2010, 25(4):206-213.
29. Spanish Resolution, 18 February 2008. http://www.boe.es/boe/dias/2008/02/18/pdfs/A09002-09003.pdf.
30. Spanish Resolution, 16 February 2009. http://www.boe.es/boe/dias/2009/02/19/pdfs/BOE-A-2009-2874.pdf.
31. Spanish Resolution, 27 February 2010. http://www.boe.es/boe/dias/2010/02/27/pdfs/BOE-A-2010-3231.pdf.
32. Spitzer R.L., Kroenke K., Williams J.B. Validation and utility of a self-report version of PRIME-MD: the PHQ primary care study. Primary care evaluation of mental disorders. Patient health questionnaire. J. Am. Med. Assoc. 1999, 282(18):1737-1744.
33. The EuroQol Group EuroQol-a new facility for the measurement of health-related quality of life. Health Policy 1990, 16(3):199-208.
34. Twisk J.W.R. Applied Multilevel Analysis: A Practical Guide 2006, Cambridge University Press, Cambridge.
35. Wade A.G., Haring J. A review of the costs associated with depression and treatment noncompliance: the potential benefits of online support. Int. Clin. Psychopharmacol. 2010, 25(5):288-296.